Director of Breast Oncology, Lifespan Cancer Institute
Assistant Professor of Medicine, Brown University
Medical Advisor, Dr. Susan Love Foundation for Breast Cancer Research
Stephanie L. Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute, and Co-Leader of the Breast Cancer Translational Research Disease Group. In addition, she serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research. She is active across numerous professional organizations in oncology, including the American Society of Clinical Oncology (ASCO) where she is a 2020 graduate of the prestigious Leadership Development Program and currently serves on the Joint Certifications Committee; the Rhode Island Leadership Council for the American Cancer Society; the on the Breast Cancer Committee for the Alliance for Clinical Trials in Oncology cooperative group; and is on the Health Disparities Council for the Caris Precision Oncology Alliance (POA) and is chair-elect for the Breast Disease group of the Caris POA. Dr. Graff is a leader on social media @DrSGraff and a sought-after public speaker.
She is also Assistant Professor of Medicine at Brown University in Providence, RI. Dr. Graff’s research interests include oncology drug development and clinical trials, the breast microbiome, breast cancer genomics, health disparities, women in medicine, and rare breast cancers including male breast cancer, pregnancy-associated breast cancer, pre-menopausal breast cancer, among others.
Dr. Graff obtained a medical degree at University of Missouri-Kansas City School of Medicine where she also completed a residency in internal medicine and later served as Chief Medicine Resident with St. Luke’s Hospital. She completed a fellowship in hematology/medical oncology and sub-fellowship in breast oncology at the University of Kansas. Before joining Lifespan, Dr. Graff held multiple positions at several locations of the Sarah Cannon Cancer Institute Network. She was National Breast Lead of Clinical Programs and Associate Director of the Breast Cancer Research Program in Nashville, TN, and Director of the Clinical Research Program in Kansas City, MO.
An active member of numerous boards of directors and professional committees, Dr. Graff has been involved with the American Cancer Society (Kansas City), the Susan Love Research Foundation, the American Society of Clinical Oncology, and other prominent organizations. She has authored and co-authored many research papers and articles related to her areas of expertise and has been invited frequently to address and lecture on medical and scientific symposia and panels.
Dr. Graff was named “Woman Disruptor of the Year” during the 2022 American Society of Clinical Oncology conference.